Split-Belt Treadmill Training to Improve Walking After Hip Fracture
NCT07923149, Not applicable, Completed, Israel Dudkiewicz
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Split-Belt Treadmill Training to Improve Walking After Hip Fracture | ClinicalTrials.gov |
| NCT number | NCT07923149 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 24 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Israel Dudkiewicz | ClinicalTrials.gov |
| Conditions | Hip Fracture | ClinicalTrials.gov |
| Interventions | Split-Belt Treadmill Training, Tied-Belt Treadmill Training | ClinicalTrials.gov |
| First posted | 2026-11-06 | ClinicalTrials.gov |
| Last updated | 2026-11-06 | ClinicalTrials.gov |
Registered outcomes 13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Change in Step-Length Gait Asymmetry | Baseline 1 (1 week before training), Baseline 2 (immediately before training), post-intervention (approximately 2 weeks after training initiation), and 4 weeks after intervention completion. | Step-length gait asymmetry was assessed during overground walking using the GAITRite electronic walkway. The signed asymmetry measure was calculated as the normalized difference between step lengths of the fractured and intact limbs, expressed as a percentage. A value of 0% indicates equal step lengths between limbs. Measurements from valid walking passes were averaged at each assessment. | ClinicalTrials.gov |
| Secondary | Change in Gait Velocity | Baseline 1 (1 week before training), Baseline 2 (immediately before training), post-intervention (approximately 2 weeks after training initiation), and 4 weeks after intervention completion. | Overground walking velocity measured using the GAITRite walkway, expressed in meters per second (m/s). | ClinicalTrials.gov |
| Secondary | Change in Cadence | Baseline 1 (1 week before training), Baseline 2 (immediately before training), post-intervention (approximately 2 weeks after training initiation), and 4 weeks after intervention completion. | Number of steps per minute during overground walking, measured using GAITRite. | ClinicalTrials.gov |
| Secondary | Change in Fractured-Limb Step Length | Baseline 1 (1 week before training), Baseline 2 (immediately before training), post-intervention (approximately 2 weeks after training initiation), and 4 weeks after intervention completion. | Mean step length of the fractured limb measured using GAITRite, expressed in centimeters. | ClinicalTrials.gov |
| Secondary | Change in Intact-Limb Step Length | Baseline 1 (1 week before training), Baseline 2 (immediately before training), post-intervention (approximately 2 weeks after training initiation), and 4 weeks after intervention completion. | Mean step length of the intact limb measured using GAITRite, expressed in centimeters. | ClinicalTrials.gov |
| Secondary | Change in Fractured-Limb Swing Phase Percentage | Baseline 1 (1 week before training), Baseline 2 (immediately before training), post-intervention (approximately 2 weeks after training initiation), and 4 weeks after intervention completion. | Percentage of the gait cycle spent in swing phase by the fractured limb, measured using GAITRite. | ClinicalTrials.gov |
| Secondary | Change in Intact-Limb Swing Phase Percentage | Baseline 1 (1 week before training), Baseline 2 (immediately before training), post-intervention (approximately 2 weeks after training initiation), and 4 weeks after intervention completion. | Percentage of the gait cycle spent in swing phase by the intact limb, measured using GAITRite. | ClinicalTrials.gov |
| Secondary | Change in Fractured-Limb Single-Limb Support Percentage | Baseline 1 (1 week before training), Baseline 2 (immediately before training), post-intervention (approximately 2 weeks after training initiation), and 4 weeks after intervention completion. | Percentage of the gait cycle during which body weight is supported by the fractured limb alone, assessed using GAITRite. | ClinicalTrials.gov |
| Secondary | Change in Intact-Limb Single-Limb Support Percentage | Baseline 1 (1 week before training), Baseline 2 (immediately before training), post-intervention (approximately 2 weeks after training initiation), and 4 weeks after intervention completion. | Percentage of the gait cycle during which body weight is supported by the intact limb alone, assessed using GAITRite. | ClinicalTrials.gov |
| Secondary | Change in Two-Minute Walk Test Distance | Baseline 1 (1 week before training), Baseline 2 (immediately before training), post-intervention (approximately 2 weeks after training initiation), and 4 weeks after intervention completion. | Total distance walked during the Two-Minute Walk Test (2MWT), expressed in meters. Higher values indicate greater walking endurance. | ClinicalTrials.gov |
| Secondary | Change in Ten-Meter Walk Test Completion Time | Baseline 1 (1 week before training), Baseline 2 (immediately before training), post-intervention (approximately 2 weeks after training initiation), and 4 weeks after intervention completion. | Time required to walk a 10-meter distance at a comfortable walking speed, expressed in seconds. Lower values indicate faster walking performance. | ClinicalTrials.gov |
| Secondary | Balance Confidence - ABC | Baseline 1 (1 week before training), post-intervention (approximately 2 weeks after training initiation), and 4 weeks after intervention completion. | Balance confidence was assessed using the Activities-Specific Balance Confidence (ABC) Scale. Participants rated their confidence in performing 16 everyday activities without losing balance, on a scale from 0 (no confidence) to 100 (complete confidence). The total score is the mean of the 16 item scores, ranging from 0 to 100. Higher scores indicate greater balance confidence. | ClinicalTrials.gov |
| Secondary | Physical Function - LLFDI-FC | Baseline 1 (1 week before training), post-intervention (approximately 2 weeks after training initiation), and 4 weeks after intervention completion. | Self-reported physical function was assessed using the Functional Component of the Late-Life Function and Disability Instrument (LLFDI-FC). Participants rated the difficulty of performing 32 everyday physical activities. Scores were transformed to a 0-100 scale, with higher scores indicating better physical function and less difficulty performing activities. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)